http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109700818-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-734 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7034 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-605 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 |
| filingDate | 2017-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109700818-B |
| titleOfInvention | A kind of pharmaceutical composition for weight loss and blood lipid lowering, preparation method and use thereof |
| abstract | The present invention relates to a pharmaceutical composition for weight loss and blood lipid lowering, and a preparation method and application thereof. The pharmaceutical composition includes the following raw materials: 22-55 parts by weight of phlorizin or a pharmaceutically acceptable salt thereof based on the weight of phlorizin; 20-73 parts by weight of pharmaceutically acceptable salts. The pharmaceutical composition not only has a significant weight loss effect, its weight loss effect is significantly better than that of a single raw material drug, and has a synergistic effect; and the pharmaceutical composition has a significant blood lipid lowering effect, and its blood lipid lowering effect is significantly better than The hypolipidemic effect of a single API has a significant synergistic effect. |
| priorityDate | 2017-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 77.